Loading…
Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine can cause haemolysis...
Saved in:
Published in: | Malaria journal 2018-06, Vol.17 (1), p.243-243, Article 243 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c560t-54457e1de3b476e2464d84a74475f4810327cac8c340a35c788fb6adbb1640323 |
---|---|
cites | cdi_FETCH-LOGICAL-c560t-54457e1de3b476e2464d84a74475f4810327cac8c340a35c788fb6adbb1640323 |
container_end_page | 243 |
container_issue | 1 |
container_start_page | 243 |
container_title | Malaria journal |
container_volume | 17 |
creator | Henriques, Gisela Phommasone, Koukeo Tripura, Rupam Peto, Thomas J Raut, Shristi Snethlage, Coco Sambo, Im Sanann, Nou Nguon, Chea Adhikari, Bipin Pongvongsa, Tiengkham Imwong, Mallika von Seidlein, Lorenz Day, Nicholas P White, Nicholas J Dondorp, Arjen M Newton, Paul Ley, Benedikt Mayxay, Mayfong |
description | Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine can cause haemolysis in G6PD deficient individuals and is, therefore, underused. Rapid diagnostic tests (RDTs) could permit ascertainment of G6PD status outside of laboratory settings and hence safe treatment in remote areas. The performance of the fluorescent spot test (Trinity, Ireland; FST) and a G6PD RDT (Carestart, USA) against spectrophotometry were assessed.
Participants were enrolled during cross-sectional surveys in Laos and by purposive sampling in Cambodia. FST and RDT were performed during village surveys and 3 mL of venous blood was collected for subsequent G6PD measurement by spectrophotometry.
A total of 757 participants were enrolled in Laos and 505 in Cambodia. FST and RDT performed best at 30% cut-off activity and performed significantly better in Laos than in Cambodia. When defining intermediate results as G6PD deficient, the FST had a sensitivity of 100% (95%CI 90-100) and specificity of 90% (95%CI 87.7-92.2) in Laos and sensitivity of 98% (94.1-99.6) and specificity of 71% (95%CI 66-76) in Cambodia (p |
doi_str_mv | 10.1186/s12936-018-2390-6 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_fa3a92b2e20d453fa7dec8b584ad2758</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A546902065</galeid><doaj_id>oai_doaj_org_article_fa3a92b2e20d453fa7dec8b584ad2758</doaj_id><sourcerecordid>A546902065</sourcerecordid><originalsourceid>FETCH-LOGICAL-c560t-54457e1de3b476e2464d84a74475f4810327cac8c340a35c788fb6adbb1640323</originalsourceid><addsrcrecordid>eNptks1u1DAUhSMEoqXwAGyQJTZsUmzHf9kgVUMLlUYCIVhbN7aT8SiJg51UmiVvjmemlA5CXtjy_e6x79EpitcEXxKixPtEaF2JEhNV0qrGpXhSnBMmeUmV5E8fnc-KFyltMSZSSfq8OKN1TWtO2HnxaxWGCaJPYUShRV2_mJBcKdC0CWnawOyQdZudjaFzIySH0gzzklCzQ22_hOiSceOM0hRmNLs0IxgtijB5i6yHbgxp9uZY8SNaQ0BfP347QCsYmpCZl8WzFvrkXt3vF8WPm-vvq8_l-sun29XVujRc4LnkjHHpiHVVw6RwlAlmFQPJ8owtUwRXVBowylQMQ8WNVKptBNimIYLlYnVR3B51bYCtnqIfIO50AK8PFyF2GmL-bO90CxXUtKGOYst41YK0zqiG5_cslVxlrQ9HrWlpBmf3FkToT0RPK6Pf6C7caYFJpQ4C7-4FYvi5ZHf04LOTfQ-jC0vSFHPFMeWCZfTtP-g2LHHMVmVKEkYVEeIv1UEewI9tyO-avai-4kzUmGLBM3X5Hyov6wZvwuhan-9PGsixwcSQUnTtw4wE630G9TGDOmdQ7zOo919589ich44_oat-A9J91tQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2071428166</pqid></control><display><type>article</type><title>Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Henriques, Gisela ; Phommasone, Koukeo ; Tripura, Rupam ; Peto, Thomas J ; Raut, Shristi ; Snethlage, Coco ; Sambo, Im ; Sanann, Nou ; Nguon, Chea ; Adhikari, Bipin ; Pongvongsa, Tiengkham ; Imwong, Mallika ; von Seidlein, Lorenz ; Day, Nicholas P ; White, Nicholas J ; Dondorp, Arjen M ; Newton, Paul ; Ley, Benedikt ; Mayxay, Mayfong</creator><creatorcontrib>Henriques, Gisela ; Phommasone, Koukeo ; Tripura, Rupam ; Peto, Thomas J ; Raut, Shristi ; Snethlage, Coco ; Sambo, Im ; Sanann, Nou ; Nguon, Chea ; Adhikari, Bipin ; Pongvongsa, Tiengkham ; Imwong, Mallika ; von Seidlein, Lorenz ; Day, Nicholas P ; White, Nicholas J ; Dondorp, Arjen M ; Newton, Paul ; Ley, Benedikt ; Mayxay, Mayfong</creatorcontrib><description>Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine can cause haemolysis in G6PD deficient individuals and is, therefore, underused. Rapid diagnostic tests (RDTs) could permit ascertainment of G6PD status outside of laboratory settings and hence safe treatment in remote areas. The performance of the fluorescent spot test (Trinity, Ireland; FST) and a G6PD RDT (Carestart, USA) against spectrophotometry were assessed.
Participants were enrolled during cross-sectional surveys in Laos and by purposive sampling in Cambodia. FST and RDT were performed during village surveys and 3 mL of venous blood was collected for subsequent G6PD measurement by spectrophotometry.
A total of 757 participants were enrolled in Laos and 505 in Cambodia. FST and RDT performed best at 30% cut-off activity and performed significantly better in Laos than in Cambodia. When defining intermediate results as G6PD deficient, the FST had a sensitivity of 100% (95%CI 90-100) and specificity of 90% (95%CI 87.7-92.2) in Laos and sensitivity of 98% (94.1-99.6) and specificity of 71% (95%CI 66-76) in Cambodia (p < 0.001). The RDT had sensitivity and specificity of 100% (95%CI 90-100) and 99% (95%CI 97-99) in Laos and sensitivity and specificity of 91% (86-96) and 93% (90-95) in Cambodia (p < 0.001). The RDT performed significantly better (all p < 0.05) than the FST when intermediate FST results were defined as G6PD deficient.
The interpretation of RDT results requires some training but is a good alternative to the FST. Trial registration clinicaltrials.gov; NCT01872702; 06/27/2013; https://clinicaltrials.gov/ct2/show/NCT01872702.</description><identifier>ISSN: 1475-2875</identifier><identifier>EISSN: 1475-2875</identifier><identifier>DOI: 10.1186/s12936-018-2390-6</identifier><identifier>PMID: 29929514</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Cambodia ; Care and treatment ; Child ; Child, Preschool ; Comparative analysis ; Dehydrogenase ; Dehydrogenases ; Diagnostic tests ; Diagnostic Tests, Routine - instrumentation ; Diagnostic Tests, Routine - methods ; Dosage and administration ; Dried Blood Spot Testing - instrumentation ; Dried Blood Spot Testing - methods ; Drug dosages ; Enzymes ; Female ; Fluorescent antibody technique ; Glucose ; Glucose-6-phosphate dehydrogenase ; Glucosephosphate dehydrogenase ; Glucosephosphate Dehydrogenase - analysis ; Glucosephosphate Dehydrogenase Deficiency - diagnosis ; Haemolysis ; Humans ; Laboratories ; Laos ; Malaria ; Male ; Medical screening ; Middle Aged ; Phosphates ; Plasmodium vivax ; Polls & surveys ; Primaquine ; Rapid diagnostic test ; Sensitivity and Specificity ; Southeast Asia ; Specificity ; Spectrophotometry ; Surveys ; Training ; Young Adult</subject><ispartof>Malaria journal, 2018-06, Vol.17 (1), p.243-243, Article 243</ispartof><rights>COPYRIGHT 2018 BioMed Central Ltd.</rights><rights>Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c560t-54457e1de3b476e2464d84a74475f4810327cac8c340a35c788fb6adbb1640323</citedby><cites>FETCH-LOGICAL-c560t-54457e1de3b476e2464d84a74475f4810327cac8c340a35c788fb6adbb1640323</cites><orcidid>0000-0002-0282-6469</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013858/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2071428166?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29929514$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Henriques, Gisela</creatorcontrib><creatorcontrib>Phommasone, Koukeo</creatorcontrib><creatorcontrib>Tripura, Rupam</creatorcontrib><creatorcontrib>Peto, Thomas J</creatorcontrib><creatorcontrib>Raut, Shristi</creatorcontrib><creatorcontrib>Snethlage, Coco</creatorcontrib><creatorcontrib>Sambo, Im</creatorcontrib><creatorcontrib>Sanann, Nou</creatorcontrib><creatorcontrib>Nguon, Chea</creatorcontrib><creatorcontrib>Adhikari, Bipin</creatorcontrib><creatorcontrib>Pongvongsa, Tiengkham</creatorcontrib><creatorcontrib>Imwong, Mallika</creatorcontrib><creatorcontrib>von Seidlein, Lorenz</creatorcontrib><creatorcontrib>Day, Nicholas P</creatorcontrib><creatorcontrib>White, Nicholas J</creatorcontrib><creatorcontrib>Dondorp, Arjen M</creatorcontrib><creatorcontrib>Newton, Paul</creatorcontrib><creatorcontrib>Ley, Benedikt</creatorcontrib><creatorcontrib>Mayxay, Mayfong</creatorcontrib><title>Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia</title><title>Malaria journal</title><addtitle>Malar J</addtitle><description>Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine can cause haemolysis in G6PD deficient individuals and is, therefore, underused. Rapid diagnostic tests (RDTs) could permit ascertainment of G6PD status outside of laboratory settings and hence safe treatment in remote areas. The performance of the fluorescent spot test (Trinity, Ireland; FST) and a G6PD RDT (Carestart, USA) against spectrophotometry were assessed.
Participants were enrolled during cross-sectional surveys in Laos and by purposive sampling in Cambodia. FST and RDT were performed during village surveys and 3 mL of venous blood was collected for subsequent G6PD measurement by spectrophotometry.
A total of 757 participants were enrolled in Laos and 505 in Cambodia. FST and RDT performed best at 30% cut-off activity and performed significantly better in Laos than in Cambodia. When defining intermediate results as G6PD deficient, the FST had a sensitivity of 100% (95%CI 90-100) and specificity of 90% (95%CI 87.7-92.2) in Laos and sensitivity of 98% (94.1-99.6) and specificity of 71% (95%CI 66-76) in Cambodia (p < 0.001). The RDT had sensitivity and specificity of 100% (95%CI 90-100) and 99% (95%CI 97-99) in Laos and sensitivity and specificity of 91% (86-96) and 93% (90-95) in Cambodia (p < 0.001). The RDT performed significantly better (all p < 0.05) than the FST when intermediate FST results were defined as G6PD deficient.
The interpretation of RDT results requires some training but is a good alternative to the FST. Trial registration clinicaltrials.gov; NCT01872702; 06/27/2013; https://clinicaltrials.gov/ct2/show/NCT01872702.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cambodia</subject><subject>Care and treatment</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Comparative analysis</subject><subject>Dehydrogenase</subject><subject>Dehydrogenases</subject><subject>Diagnostic tests</subject><subject>Diagnostic Tests, Routine - instrumentation</subject><subject>Diagnostic Tests, Routine - methods</subject><subject>Dosage and administration</subject><subject>Dried Blood Spot Testing - instrumentation</subject><subject>Dried Blood Spot Testing - methods</subject><subject>Drug dosages</subject><subject>Enzymes</subject><subject>Female</subject><subject>Fluorescent antibody technique</subject><subject>Glucose</subject><subject>Glucose-6-phosphate dehydrogenase</subject><subject>Glucosephosphate dehydrogenase</subject><subject>Glucosephosphate Dehydrogenase - analysis</subject><subject>Glucosephosphate Dehydrogenase Deficiency - diagnosis</subject><subject>Haemolysis</subject><subject>Humans</subject><subject>Laboratories</subject><subject>Laos</subject><subject>Malaria</subject><subject>Male</subject><subject>Medical screening</subject><subject>Middle Aged</subject><subject>Phosphates</subject><subject>Plasmodium vivax</subject><subject>Polls & surveys</subject><subject>Primaquine</subject><subject>Rapid diagnostic test</subject><subject>Sensitivity and Specificity</subject><subject>Southeast Asia</subject><subject>Specificity</subject><subject>Spectrophotometry</subject><subject>Surveys</subject><subject>Training</subject><subject>Young Adult</subject><issn>1475-2875</issn><issn>1475-2875</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptks1u1DAUhSMEoqXwAGyQJTZsUmzHf9kgVUMLlUYCIVhbN7aT8SiJg51UmiVvjmemlA5CXtjy_e6x79EpitcEXxKixPtEaF2JEhNV0qrGpXhSnBMmeUmV5E8fnc-KFyltMSZSSfq8OKN1TWtO2HnxaxWGCaJPYUShRV2_mJBcKdC0CWnawOyQdZudjaFzIySH0gzzklCzQ22_hOiSceOM0hRmNLs0IxgtijB5i6yHbgxp9uZY8SNaQ0BfP347QCsYmpCZl8WzFvrkXt3vF8WPm-vvq8_l-sun29XVujRc4LnkjHHpiHVVw6RwlAlmFQPJ8owtUwRXVBowylQMQ8WNVKptBNimIYLlYnVR3B51bYCtnqIfIO50AK8PFyF2GmL-bO90CxXUtKGOYst41YK0zqiG5_cslVxlrQ9HrWlpBmf3FkToT0RPK6Pf6C7caYFJpQ4C7-4FYvi5ZHf04LOTfQ-jC0vSFHPFMeWCZfTtP-g2LHHMVmVKEkYVEeIv1UEewI9tyO-avai-4kzUmGLBM3X5Hyov6wZvwuhan-9PGsixwcSQUnTtw4wE630G9TGDOmdQ7zOo919589ich44_oat-A9J91tQ</recordid><startdate>20180622</startdate><enddate>20180622</enddate><creator>Henriques, Gisela</creator><creator>Phommasone, Koukeo</creator><creator>Tripura, Rupam</creator><creator>Peto, Thomas J</creator><creator>Raut, Shristi</creator><creator>Snethlage, Coco</creator><creator>Sambo, Im</creator><creator>Sanann, Nou</creator><creator>Nguon, Chea</creator><creator>Adhikari, Bipin</creator><creator>Pongvongsa, Tiengkham</creator><creator>Imwong, Mallika</creator><creator>von Seidlein, Lorenz</creator><creator>Day, Nicholas P</creator><creator>White, Nicholas J</creator><creator>Dondorp, Arjen M</creator><creator>Newton, Paul</creator><creator>Ley, Benedikt</creator><creator>Mayxay, Mayfong</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7SS</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F1W</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>H95</scope><scope>H97</scope><scope>K9.</scope><scope>L.G</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0282-6469</orcidid></search><sort><creationdate>20180622</creationdate><title>Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia</title><author>Henriques, Gisela ; Phommasone, Koukeo ; Tripura, Rupam ; Peto, Thomas J ; Raut, Shristi ; Snethlage, Coco ; Sambo, Im ; Sanann, Nou ; Nguon, Chea ; Adhikari, Bipin ; Pongvongsa, Tiengkham ; Imwong, Mallika ; von Seidlein, Lorenz ; Day, Nicholas P ; White, Nicholas J ; Dondorp, Arjen M ; Newton, Paul ; Ley, Benedikt ; Mayxay, Mayfong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c560t-54457e1de3b476e2464d84a74475f4810327cac8c340a35c788fb6adbb1640323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cambodia</topic><topic>Care and treatment</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Comparative analysis</topic><topic>Dehydrogenase</topic><topic>Dehydrogenases</topic><topic>Diagnostic tests</topic><topic>Diagnostic Tests, Routine - instrumentation</topic><topic>Diagnostic Tests, Routine - methods</topic><topic>Dosage and administration</topic><topic>Dried Blood Spot Testing - instrumentation</topic><topic>Dried Blood Spot Testing - methods</topic><topic>Drug dosages</topic><topic>Enzymes</topic><topic>Female</topic><topic>Fluorescent antibody technique</topic><topic>Glucose</topic><topic>Glucose-6-phosphate dehydrogenase</topic><topic>Glucosephosphate dehydrogenase</topic><topic>Glucosephosphate Dehydrogenase - analysis</topic><topic>Glucosephosphate Dehydrogenase Deficiency - diagnosis</topic><topic>Haemolysis</topic><topic>Humans</topic><topic>Laboratories</topic><topic>Laos</topic><topic>Malaria</topic><topic>Male</topic><topic>Medical screening</topic><topic>Middle Aged</topic><topic>Phosphates</topic><topic>Plasmodium vivax</topic><topic>Polls & surveys</topic><topic>Primaquine</topic><topic>Rapid diagnostic test</topic><topic>Sensitivity and Specificity</topic><topic>Southeast Asia</topic><topic>Specificity</topic><topic>Spectrophotometry</topic><topic>Surveys</topic><topic>Training</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Henriques, Gisela</creatorcontrib><creatorcontrib>Phommasone, Koukeo</creatorcontrib><creatorcontrib>Tripura, Rupam</creatorcontrib><creatorcontrib>Peto, Thomas J</creatorcontrib><creatorcontrib>Raut, Shristi</creatorcontrib><creatorcontrib>Snethlage, Coco</creatorcontrib><creatorcontrib>Sambo, Im</creatorcontrib><creatorcontrib>Sanann, Nou</creatorcontrib><creatorcontrib>Nguon, Chea</creatorcontrib><creatorcontrib>Adhikari, Bipin</creatorcontrib><creatorcontrib>Pongvongsa, Tiengkham</creatorcontrib><creatorcontrib>Imwong, Mallika</creatorcontrib><creatorcontrib>von Seidlein, Lorenz</creatorcontrib><creatorcontrib>Day, Nicholas P</creatorcontrib><creatorcontrib>White, Nicholas J</creatorcontrib><creatorcontrib>Dondorp, Arjen M</creatorcontrib><creatorcontrib>Newton, Paul</creatorcontrib><creatorcontrib>Ley, Benedikt</creatorcontrib><creatorcontrib>Mayxay, Mayfong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest - Health & Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals (DOAJ)</collection><jtitle>Malaria journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Henriques, Gisela</au><au>Phommasone, Koukeo</au><au>Tripura, Rupam</au><au>Peto, Thomas J</au><au>Raut, Shristi</au><au>Snethlage, Coco</au><au>Sambo, Im</au><au>Sanann, Nou</au><au>Nguon, Chea</au><au>Adhikari, Bipin</au><au>Pongvongsa, Tiengkham</au><au>Imwong, Mallika</au><au>von Seidlein, Lorenz</au><au>Day, Nicholas P</au><au>White, Nicholas J</au><au>Dondorp, Arjen M</au><au>Newton, Paul</au><au>Ley, Benedikt</au><au>Mayxay, Mayfong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia</atitle><jtitle>Malaria journal</jtitle><addtitle>Malar J</addtitle><date>2018-06-22</date><risdate>2018</risdate><volume>17</volume><issue>1</issue><spage>243</spage><epage>243</epage><pages>243-243</pages><artnum>243</artnum><issn>1475-2875</issn><eissn>1475-2875</eissn><abstract>Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide. Primaquine is the only licensed drug that effectively removes Plasmodium vivax hypnozoites from the human host and prevents relapse. While well tolerated by most recipients, primaquine can cause haemolysis in G6PD deficient individuals and is, therefore, underused. Rapid diagnostic tests (RDTs) could permit ascertainment of G6PD status outside of laboratory settings and hence safe treatment in remote areas. The performance of the fluorescent spot test (Trinity, Ireland; FST) and a G6PD RDT (Carestart, USA) against spectrophotometry were assessed.
Participants were enrolled during cross-sectional surveys in Laos and by purposive sampling in Cambodia. FST and RDT were performed during village surveys and 3 mL of venous blood was collected for subsequent G6PD measurement by spectrophotometry.
A total of 757 participants were enrolled in Laos and 505 in Cambodia. FST and RDT performed best at 30% cut-off activity and performed significantly better in Laos than in Cambodia. When defining intermediate results as G6PD deficient, the FST had a sensitivity of 100% (95%CI 90-100) and specificity of 90% (95%CI 87.7-92.2) in Laos and sensitivity of 98% (94.1-99.6) and specificity of 71% (95%CI 66-76) in Cambodia (p < 0.001). The RDT had sensitivity and specificity of 100% (95%CI 90-100) and 99% (95%CI 97-99) in Laos and sensitivity and specificity of 91% (86-96) and 93% (90-95) in Cambodia (p < 0.001). The RDT performed significantly better (all p < 0.05) than the FST when intermediate FST results were defined as G6PD deficient.
The interpretation of RDT results requires some training but is a good alternative to the FST. Trial registration clinicaltrials.gov; NCT01872702; 06/27/2013; https://clinicaltrials.gov/ct2/show/NCT01872702.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>29929514</pmid><doi>10.1186/s12936-018-2390-6</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-0282-6469</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1475-2875 |
ispartof | Malaria journal, 2018-06, Vol.17 (1), p.243-243, Article 243 |
issn | 1475-2875 1475-2875 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_fa3a92b2e20d453fa7dec8b584ad2758 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central |
subjects | Adolescent Adult Aged Aged, 80 and over Cambodia Care and treatment Child Child, Preschool Comparative analysis Dehydrogenase Dehydrogenases Diagnostic tests Diagnostic Tests, Routine - instrumentation Diagnostic Tests, Routine - methods Dosage and administration Dried Blood Spot Testing - instrumentation Dried Blood Spot Testing - methods Drug dosages Enzymes Female Fluorescent antibody technique Glucose Glucose-6-phosphate dehydrogenase Glucosephosphate dehydrogenase Glucosephosphate Dehydrogenase - analysis Glucosephosphate Dehydrogenase Deficiency - diagnosis Haemolysis Humans Laboratories Laos Malaria Male Medical screening Middle Aged Phosphates Plasmodium vivax Polls & surveys Primaquine Rapid diagnostic test Sensitivity and Specificity Southeast Asia Specificity Spectrophotometry Surveys Training Young Adult |
title | Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T11%3A16%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20glucose-6%20phosphate%20dehydrogenase%20status%20by%20fluorescent%20spot%20test%20and%20rapid%20diagnostic%20test%20in%20Lao%20PDR%20and%20Cambodia&rft.jtitle=Malaria%20journal&rft.au=Henriques,%20Gisela&rft.date=2018-06-22&rft.volume=17&rft.issue=1&rft.spage=243&rft.epage=243&rft.pages=243-243&rft.artnum=243&rft.issn=1475-2875&rft.eissn=1475-2875&rft_id=info:doi/10.1186/s12936-018-2390-6&rft_dat=%3Cgale_doaj_%3EA546902065%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c560t-54457e1de3b476e2464d84a74475f4810327cac8c340a35c788fb6adbb1640323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2071428166&rft_id=info:pmid/29929514&rft_galeid=A546902065&rfr_iscdi=true |